1. Home
  2. MIDD vs VRNA Comparison

MIDD vs VRNA Comparison

Compare MIDD & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIDD
  • VRNA
  • Stock Information
  • Founded
  • MIDD 1888
  • VRNA 2005
  • Country
  • MIDD United States
  • VRNA United Kingdom
  • Employees
  • MIDD N/A
  • VRNA N/A
  • Industry
  • MIDD Industrial Machinery/Components
  • VRNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIDD Industrials
  • VRNA Health Care
  • Exchange
  • MIDD Nasdaq
  • VRNA Nasdaq
  • Market Cap
  • MIDD 7.9B
  • VRNA 8.3B
  • IPO Year
  • MIDD N/A
  • VRNA 2017
  • Fundamental
  • Price
  • MIDD $150.64
  • VRNA $104.97
  • Analyst Decision
  • MIDD Buy
  • VRNA Buy
  • Analyst Count
  • MIDD 7
  • VRNA 11
  • Target Price
  • MIDD $169.00
  • VRNA $114.10
  • AVG Volume (30 Days)
  • MIDD 867.2K
  • VRNA 7.5M
  • Earning Date
  • MIDD 08-04-2025
  • VRNA 08-07-2025
  • Dividend Yield
  • MIDD N/A
  • VRNA N/A
  • EPS Growth
  • MIDD 11.43
  • VRNA N/A
  • EPS
  • MIDD 8.00
  • VRNA N/A
  • Revenue
  • MIDD $3,854,863,000.00
  • VRNA $118,535,000.00
  • Revenue This Year
  • MIDD $2.96
  • VRNA $893.95
  • Revenue Next Year
  • MIDD $3.56
  • VRNA $73.76
  • P/E Ratio
  • MIDD $18.69
  • VRNA N/A
  • Revenue Growth
  • MIDD N/A
  • VRNA N/A
  • 52 Week Low
  • MIDD $121.70
  • VRNA $18.51
  • 52 Week High
  • MIDD $182.73
  • VRNA $105.30
  • Technical
  • Relative Strength Index (RSI)
  • MIDD 50.30
  • VRNA 70.71
  • Support Level
  • MIDD $144.29
  • VRNA $104.58
  • Resistance Level
  • MIDD $149.10
  • VRNA $105.30
  • Average True Range (ATR)
  • MIDD 3.47
  • VRNA 1.22
  • MACD
  • MIDD -0.25
  • VRNA 0.06
  • Stochastic Oscillator
  • MIDD 44.59
  • VRNA 97.94

About MIDD Middleby Corporation (The)

The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

Share on Social Networks: